Merit Medical Systems Inc

The global microcatheter market is valued at USD 1.05 billion in 2025 and is projected to reach USD 1.79 billion by 2035, expanding at a CAGR of 5.53%. Growth is driven by increasing adoption of minimally invasive cardiovascular and neurovascular procedures, rising prevalence of cardiovascular and neurovascular disorders, and advancements in cath...

Merit Medical Systems has acquired View Point Medical, Inc. for approximately $140 million ($90 million cash at closing plus $25 million deferred payments over two years). View Point manufactures the OneMark Detection Imaging System for breast and soft tissue tumor localization. The acquisition is expected to be dilutive to Merit's 2026 earnings ...

The global uterine fibroid market is projected to grow from USD 5.26 billion in 2025 to USD 9.43 billion by 2033 at a CAGR of 7.63%. Growth is driven by rising prevalence of fibroids (affecting 70-80% of women by age 50), technological advances in minimally invasive procedures with 60% adoption increase, and expanded healthcare infrastructure in ...

Merit, a global engagement and incentives technology company headquartered in Riyadh, has acquired Synchro Marketing, an Australian leader in sales incentive programs for automotive and oil & gas sectors. The acquisition accelerates Merit's global expansion and enhances its sector-specific capabilities, particularly in the APAC region. Synchro wi...

Merit Medical Systems has signed an asset purchase agreement with PENTAX Medical to acquire the C2 CryoBalloon device for $22 million, expanding its endoscopy portfolio in the gastroenterology market with technology to treat Barrett's esophagus and other gastrointestinal disorders.